Jonathan Fox

Jonathan Fox

Fortune : 837 398 $ au 31/05/2026

68 ans
Health Technology
Consumer Services

Profil

Jonathan C.
Fox
is currently Independent Director at Edgewise Therapeutics, Inc. since 2023, Director at ML Bio Solutions, Inc., Trustee at Lankenau Institute for Medical Research, President & Chief Medical Officer at Eidos Therapeutics, Inc. since 2016, and President & Chief Medical Officer-Cardiovascular at BridgeBio Pharma, Inc. since 2016.
Former positions include Senior Director-Clinical Cardiovascular Research at Merck & Co., Inc., Director-Clinical Pharmacology at GlaxoSmithKline LLC, Chief Medical Officer at MyoKardia, Inc. from 2013 to 2016, Consulting Professor at Stanford University, Clinical Professor at the University of Pennsylvania, Consultant at The University of California, San Francisco, and Vice President-Clinical Development at AstraZeneca LP in 2012.
Education includes undergraduate and doctorate degrees from The University of Chicago.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/06/2026 24 514 ( 0,02% ) 837 398 $ 31/05/2026

Postes actifs de Jonathan Fox

SociétésPosteDébut
EIDOS THERAPEUTICS, INC. President 01/10/2016
EDGEWISE THERAPEUTICS, INC. Directeur/Membre du Conseil 02/03/2023
BRIDGEBIO PHARMA, INC. Corporate Officer/Principal 01/01/2016
ML Bio Solutions, Inc.
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Jonathan Fox

SociétésPosteFin
MYOKARDIA, INC. Directeur Technique/Scientifique/R&D 30/09/2016
Directeur Technique/Scientifique/R&D 01/01/2012
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░░░ ░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Jonathan Fox

Formation de Jonathan Fox

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

28

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

ML Bio Solutions, Inc.

  1. Bourse
  2. Insiders
  3. Jonathan Fox